Flupamid

Quick links to important sections

Flupamid

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flupamid

Property Description
Active ingredient Indapamide
Form Tablets (including prolonged-release)
Pharmacological class Thiazide-like Diuretic
Common purpose Lowering High Blood Pressure (Antihypertensive Agent)
Origin Synthetic (Indoline derivative)

What is Flupamid and What is its Classification?

Flupamid is a prescription-only medication that functions primarily as an antihypertensive agent, meaning its principal purpose is to manage and lower high blood pressure. Pharmacologically, it belongs to the class of diuretics, agents designed to increase the excretion of fluid from the body. Its active ingredient is Indapamide, a compound classified as an indoline derivative and a sulfamoyl-containing diuretic. This synthetic origin and specific chemical structure are clinically recognized for providing a distinct pharmacological profile in blood pressure management.


Flupamid's Composition and Unique Diuretic Type

The sole active ingredient in Flupamid is Indapamide, confirming it as a single-ingredient product used in monotherapy. Indapamide is precisely defined as a thiazide-like diuretic because its action profile extends beyond that of classical thiazides. This distinction is crucial: in addition to promoting diuresis (increased urine excretion), Indapamide exerts a unique, direct relaxing effect on the vascular smooth muscle. This action is instrumental in reducing peripheral vascular resistance. This dual action provides a benefit in reducing cardiovascular risk. For oral administration, Flupamid is typically supplied as tablets, film-coated tablets, or prolonged-release tablets, a format designed for once-daily dosing regularity.


What is the Primary General Purpose of Flupamid?

The core purpose of Flupamid is to provide effective, long-term management of chronic hypertension, a common scenario being its long-term use in adult patients requiring maintenance therapy for consistently elevated blood pressure. Thiazide-like diuretics are considered an established and effective first-line treatment option for uncomplicated hypertension. This benefit is achieved through its two complementary physiological effects: the elimination of excess fluid volume and the easing of tension in the blood vessel walls. By reducing the circulating fluid load and widening the arteries, Flupamid acts as a comprehensive antihypertensive agent that lessens the overall strain on the heart and circulatory system.

Regulatory References

  1. NIH

What side effects are possible with Flupamid?

Possible side effects and safety information

The safety profile of Flupamid (Indapamide) is categorized according to official regulatory standards, which classify potential adverse reactions based on their frequency of observation in clinical use, ranging from Very Common to Not Known.

Frequency-Classified Adverse Reactions

The most frequently documented safety concerns relate to Metabolism and Nutrition Disorders, specifically Hypokalaemia (low potassium levels in the blood), which is officially classified as a Common adverse reaction. Other Common effects include dermatological reactions such as maculopapular rashes, indicating a potential for hypersensitivity.

Reactions categorized as Uncommon include vomiting, hyponatraemia (low sodium), and purpura. Rare effects include headache, fatigue, dizziness, and gastrointestinal complaints like nausea and constipation. The official label also lists Very Rare serious events, which include blood disorders (e.g., agranulocytosis), severe skin reactions (e.g., Stevens-Johnson Syndrome), pancreatitis, and renal failure.

Serious Adverse Reactions and Systemic Concerns

Officially documented serious adverse reactions include Acute Angle-Closure Glaucoma and Choroidal Effusion (ocular disorders potentially leading to vision loss), and Hepatic Encephalopathy (a serious neurological condition linked to liver impairment). These, alongside Torsade de Pointes (a potentially fatal heart rhythm disorder), define the scope of critical, though rare, systemic risks.

Population-Specific Safety Considerations

The regulatory label includes specific warnings regarding usage for certain populations. The medicine is contraindicated in patients with severe renal impairment or severe hepatic impairment (liver disease). Additionally, older adults may be at increased risk for severe hyponatraemia. Time-related patterns are noted, specifying that transient effects like dizziness and fatigue are more likely to occur upon the initiation of treatment or following adjustments in amount.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Flupamid is associated with a specific profile of severe physiological effects, primarily involving pronounced fluid loss and electrolyte disturbances. The most significant manifestations documented in regulatory sources are severe hypotension (excessively low blood pressure) and the depletion of critical electrolytes such as hypokalemia (low potassium) and hyponatremia (low sodium).

Clinically, an overdose may present with signs of central nervous system involvement, including drowsiness, dizziness, confusion, restlessness, and potential syncope (fainting), alongside gastrointestinal symptoms like nausea and vomiting. The severe electrolyte shifts pose a life-threatening risk, including the documented possibility of QTc prolongation leading to Torsade de pointes, a potentially fatal cardiac arrhythmia.

Immediate medical attention must be sought for any suspected overdose. Regulator-mandated response involves initiating symptomatic and supportive treatment immediately, as no specific antidote is known. Management focuses on urgent fluid replacement and the correction of electrolyte imbalances under close hospital monitoring. Special consideration is noted for elderly females due to higher reporting of severe hyponatremia and for patients with hepatic impairment, who face a heightened risk of hepatic encephalopathy.

Therapeutic Uses of Flupamid

Primary Uses and Benefits of Flupamid (Indapamide)

Flupamid, featuring the active ingredient Indapamide, is generally an antihypertensive agent that plays a role in managing chronic conditions related to systemic imbalance. The medication's uses include addressing pressure and fluid imbalance.


Therapeutic Action and Relief

The medication is relevant for easing the burden of conditions marked by increased physiological stress, including chronic hypertension and edema (fluid retention). The primary therapeutic benefit includes the sustained lowering of elevated vascular pressure, which provides support that helps ease the overall symptom burden linked to systemic imbalance. It is also applied across domains where additional symptomatic support for fluid imbalance is needed, managing symptom clusters associated with excess fluid volume, such as visible swelling or general puffiness.

“This is commonly used in contexts where sustained control is relevant, supporting the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Pressure Overload

The medication is commonly used to help manage the pressure symptoms linked to chronic systemic vascular stress, offering symptomatic relief that helps patients cope more steadily with symptom fluctuations and may assist with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Flupamid

Flupamid (Indapamide) eligibility is defined by official regulatory documentation, primarily based on the patient's existing health status, specific comorbidities, and age.

Contraindicated Populations

Use of Flupamid is absolutely contraindicated in patients presenting with:

  • Severe Organ Dysfunction: This includes Anuria or severe renal failure, as well as severe hepatic impairment or hepatic encephalopathy.
  • Electrolyte Imbalance: Individuals with pre-existing Hypokalaemia (low potassium levels) must not use the medication.
  • Hypersensitivity: Known allergy to Indapamide or any sulfonamide-derived drugs.

Age and Physiological Restrictions

Category Regulatory Status
Pediatric Population Not recommended; safety and efficacy are not established in children and adolescents.
Pregnancy Not recommended for routine use; indicated only for pathological edema.
Lactation Contraindicated in nursing mothers.

Conditional Use and Special Considerations

Eligibility is conditional and requires strict medical supervision and monitoring for adults with coexisting conditions such as Diabetes Mellitus, Gout or Hyperuricemia, and Systemic Lupus Erythematosus (SLE). Caution is also required in older adults due to increased risk of electrolyte imbalance.

What should I know about interactions with other medicines?

The interaction profile of Flupamid (Indapamide) is defined by its effects on electrolytes and blood pressure, leading to specific regulatory constraints when co-administered with other substances.

Interaction Classifications

Classification (Regulatory Basis) Key Interacting Substances Official Interaction Outcome
Contraindicated or Not Recommended Lithium Reduced renal clearance of Lithium, potentially leading to increased plasma concentrations and overdosage risk.
Contraindicated or Not Recommended Torsades de pointes-inducing agents (e.g., Amiodarone, Moxifloxacin) Highly increased risk of severe ventricular arrhythmias, primarily due to Flupamid-induced low potassium (hypokalaemia).

Pharmacodynamic and Exposure-Modifying Interactions

Other agents are noted in official documents as requiring caution due to their pharmacodynamic effects when combined with Flupamid:

  • Other Antihypertensive Agents: Co-administration results in an additive hypotensive effect, increasing the potential for low blood pressure.
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): These may reduce the intended antihypertensive effect and increase the risk of acute renal failure in patients who are dehydrated.
  • Potassium-Depleting Agents (e.g., Corticosteroids, Stimulant Laxatives): Combining these with Flupamid increases the risk of hypokalaemia due to additive potassium loss.
  • Digitalis Preparations: Low potassium levels induced by Flupamid can predispose the patient to the toxic effects of digitalis on the heart.
  • Alcohol: Consumption may officially potentiate the effects of blood pressure-lowering agents, potentially worsening orthostatic hypotension (dizziness upon standing).

There are no mandatory separation timing rules documented in the primary regulatory sources for the monotherapy product. Caution regarding potential precipitation of hepatic encephalopathy is noted for patients with severe hepatic impairment, as minor fluid and electrolyte changes can exacerbate this condition.

Mechanism of Action

The active ingredient in Flupamid, Indapamide, operates via a dual pharmacodynamic mechanism involving the kidney and the systemic vasculature. In the kidney's distal convoluted tubule, Indapamide selectively acts as an inhibitor of the Sodium-Chloride Cotransporter (NCC). This inhibition prevents the reabsorption of Na^+ and Cl^-, causing increased salt and water excretion. The resultant loss of electrolytes and water alters the flux of volume, leading to a reduction in overall circulating plasma volume. Simultaneously, Indapamide exerts a direct, non-diuretic effect on the smooth muscle cells of small arteries. This involves modifying cellular activity, specifically by reducing the intracellular concentration of calcium ions ( Ca^2+) required for contraction. This action modifies arterial smooth muscle tone, causing the blood vessels to widen and thus reducing peripheral vascular resistance (PVR). The simultaneous reduction in plasma volume and PVR constitutes the integrated physiological change in arterial pressure.

Dosage and Administration Information

Flupamid is an oral medication used as a component of a long-term treatment plan, typically for chronic hypertension. Its usage protocol is highly standardized, focusing on a once-daily regimen to ensure consistent therapeutic action throughout a 24-hour period.

Administration is exclusively by mouth, available in both Immediate-Release (IR) and Prolonged-Release (SR) tablets. For the treatment of high blood pressure, the recommended starting dose for the IR formulation is typically 1.25 mg once daily, with the dose potentially increasing up to a maximum of 5 mg. The SR tablets are commonly dosed at 1.5 mg once daily, and this dose is usually considered the maximum for enhancing the blood pressure-lowering effect.

The tablet should be taken preferably in the morning, and may be ingested with or without food. A key procedural constraint is that the prolonged-release tablets must be swallowed whole and not crushed or chewed to maintain the controlled-release mechanism. Dosage adjustments, if required, are implemented conservatively, often at intervals of four weeks or longer, allowing the previous dose time to reach its full therapeutic effect. If a dose is missed, the instruction is to skip the forgotten dose and resume the regular schedule, without taking a double dose. Flupamid is officially not recommended for use in children and adolescents, and its use is contraindicated in patients with severe hepatic or renal impairment.

Recent Clinical Evidence

Flupamid: Recent Clinical Evidence

Evidence for use in Chronic Hypertension

Research exploring Flupamid (active ingredient Indapamide) in research settings exploring Chronic Hypertension includes multiple large-scale Randomized Controlled Trials (RCTs) and systematic reviews. These studies were conducted to study the effects of the agent in adults diagnosed with consistently high blood pressure. Trials typically monitored changes in Systolic and Diastolic Blood Pressure (BP), along with high-level clinical endpoints such as the overall rate of Major Cardiovascular Events (MACE), the occurrence of stroke, and the onset of Heart failure.


Evidence for use in Secondary Cardiovascular Prevention

Research explored the use of Flupamid in patients who had already experienced a cardiovascular event, such as a stroke or transient ischemic attack (TIA). The main outcomes examined in these studies included the recurrence of fatal and non-fatal stroke, along with rates of cardiovascular death.


Long-term Follow-up and Evidence in Special Populations

Most long-term data for high-level outcomes (such as stroke and death) were derived from studies where Indapamide was used as a combination therapy with a second drug. Follow-up periods for these large studies typically extended over medium to long-term intervals (two to four years). The agent was evaluated in specific trials involving older adults (aged 80 years and above) and patients with co-existing conditions, such as Type 2 Diabetes Mellitus.


Research Gaps and What Remains Uncertain

The available evidence for Flupamid has several limitations and is still being collected in certain areas. Data for certain groups remain insufficient to fully isolate the long-term impact of Indapamide when used as the only medicine (monotherapy) for hard clinical outcomes. Furthermore, results apply only to the populations studied, meaning research exploring the frailest patients remains limited.

Frequently Asked Questions (FAQ)

Common questions about Flupamid (FAQ)

Q: How quickly do people typically start to notice effects from Flupamid?

Studies indicate that Flupamid's full therapeutic effect can take time to develop. For this reason, official prescribing information notes that healthcare providers typically wait four weeks or more before considering any dosage adjustments. This timeframe is used to assess the previous dose’s full therapeutic effect.


Q: Are there any long-term health concerns associated with using Flupamid?

The adverse reaction profile is documented in official sources and includes potential risks for long-term use. Official documents list very rare but serious events, including severe blood disorders, severe skin reactions, and renal failure. These potential risks inform the ongoing health monitoring that is typically considered for long-term use.


Q: What foods or drinks should people generally be careful about when taking Flupamid?

Regulatory documents state that Flupamid can be taken with or without food. However, regulatory warnings describe a potential interaction with alcohol consumption. Alcohol may increase the blood pressure-lowering effect of the medication, which could potentially worsen dizziness when standing up (orthostatic hypotension).


Q: How does Flupamid compare to other drugs used for the same general condition?

Official classifications identify the active ingredient in Flupamid as a thiazide-like diuretic, a specific type of water pill. Pharmacokinetic data indicates that it has a longer duration of action compared to some older thiazide-type diuretics. This longer action is linked to its suitability for a once-daily regimen.


Q: Can Flupamid cause dry mouth or changes in vision?

Official documents list dry mouth as a Rare side effect associated with the use of Flupamid. Separately, the medication carries warnings for specific ocular disorders, such as Acute Angle-Closure Glaucoma and Choroidal Effusion, which are listed as serious adverse reactions that can affect vision.


Q: What are the most common reasons people stop taking Flupamid?

Based on official safety classifications, the most frequently documented adverse reaction is Hypokalaemia, which means having low potassium levels in the blood. Regulatory documents indicate that monitoring for this issue informs clinical decisions regarding dosage adjustment or continuation of the medication.


Q: Does taking Flupamid require any special monitoring or regular blood tests?

Official warnings emphasize the need for regular monitoring of plasma potassium and plasma sodium levels. This monitoring is particularly important at the beginning of treatment, for older adults, and for patients with other co-existing health conditions, as electrolyte imbalances are a known risk.


Q: What are the official clinical trial results for Flupamid?

Clinical studies and official information show that the active ingredient in Flupamid produces dose-related antihypertensive effects. Trials were designed to measure changes in Systolic and Diastolic Blood Pressure and demonstrate the reduction of major cardiovascular outcomes, such as stroke and heart failure, in the populations studied.


Q: How long does it take for side effects of Flupamid to go away?

Official product information notes that certain minor side effects, such as dizziness and fatigue, are classified as transient effects. This suggests they are more likely to occur upon the initiation of treatment or following a dose adjustment and generally tend to resolve over time as the body adjusts.


Q: Can Flupamid cause changes in weight or appetite?

Official adverse event data includes both loss of appetite and reports of unusual weight gain or loss. These are generally listed among the less common side effects reported during clinical use.


Q: Is Flupamid available as a generic medicine?

The active ingredient in Flupamid, Indapamide, is available in the United States and globally as a generic medication. This status allows other manufacturers to produce the same active compound once the original patent has expired.


Q: Why do some people experience stomach upset with Flupamid?

Gastrointestinal disturbances are among the reported side effects of Flupamid. Regulatory documents classify complaints such as nausea, vomiting, and constipation as Uncommon or Rare adverse reactions that can occur with use.


Q: Does Flupamid affect sleep patterns?

The safety profile for Flupamid includes effects related to sleep and consciousness. Listed adverse reactions include both drowsiness or sleepiness and the opposite effect, insomnia (difficulty sleeping).


Q: Are there any warnings about driving or operating machinery while on Flupamid?

Official warnings caution that the possibility of experiencing dizziness or fatigue may impair the ability to drive or operate machinery. This risk is noted to be highest when treatment is initiated or after the dose has been increased.


Q: How long does Flupamid typically stay in a person's system?

According to pharmacokinetic data, the amount of time Flupamid remains in the bloodstream is described by its elimination half-life. The half-life for the active ingredient is approximately 14 hours for Immediate-Release tablets and can be up to 24 hours for Slow-Release formulations.


Q: Is there a risk of dependency or withdrawal when stopping Flupamid?

Official regulatory warnings do not indicate that Flupamid carries a risk of dependency. Furthermore, studies have shown no evidence of rebound hypertension (a rapid and severe return of high blood pressure) when the medication is withdrawn.


Q: Do lifestyle changes affect how well Flupamid works?

While Flupamid provides pharmacological management for blood pressure, regulatory guidance confirms that specific lifestyle factors are relevant. For example, excessive alcohol consumption and non-compliance with sodium restriction are factors noted to influence overall blood pressure control.


Q: Does Flupamid interact with herbal supplements?

Official regulatory documents do not provide a comprehensive list of all potential herbal supplement interactions. However, general caution is advised when combining Flupamid with any agent, including herbs, that may cause a significant loss of potassium or possess an additional diuretic effect.


Q: Can Flupamid be taken with antacids or heartburn medicine?

Official drug monographs specifically indicate that antacids have been reported to have no effect on the activity or absorption of Flupamid. Individuals who have concerns about this or any other specific food/drug combination should seek guidance from a healthcare provider.


Q: Does Flupamid have a boxed warning in official drug information?

The official documentation for the single-ingredient formulation of Flupamid does not typically contain a stand-alone boxed warning (also known as a black box warning). However, certain combination products that contain the active ingredient may carry specific warnings, such as those related to fetal toxicity.


Q: Does Flupamid interact with grapefruit?

Official labeling may not explicitly name grapefruit as a concern. However, regulatory guidance often advises caution, as grapefruit juice has the potential to interfere with the body's processing of many medications, particularly those that affect certain liver enzymes.


Q: Is Flupamid a controlled substance?

No, regulatory agencies like the US DEA or Health Canada have not classified the active ingredient in Flupamid as a controlled substance. It is categorized as a prescription-only medication for blood pressure management.


Q: What does the term 'contraindication' mean for Flupamid?

In regulatory terms, a contraindication is a strict condition that makes the use of a medicine prohibited. For Flupamid, examples include pre-existing severe kidney or liver disease, as using the drug in these conditions is considered highly unsafe due to potential risks.


Q: What happens if you take more than the typical prescribed amount of Flupamid?

Official information describes that an overdose can lead to symptoms primarily related to fluid and electrolyte imbalances. These can include severe low blood pressure (hypotension), dizziness, confusion, and muscle cramps.


Q: Are there different brand names for the same active ingredient as Flupamid?

Yes, the active ingredient Indapamide is marketed globally under several different trade names. Examples of other brand names include Natrilix, Lozol, and Rawel.

--.-

Q: Does Flupamid cause sensitivity to the sun?

Yes, the safety profile states that Flupamid can cause photosensitivity, which is an increased sensitivity of the skin to sunlight. Because of this, patients are advised to take precautions against severe sunburn while using the medication.

How should Flupamid be stored and disposed of?

How to Store and Dispose of Flupamid (Indapamide)

Official regulatory documents define strict storage and disposal requirements for Indapamide-containing products.

Storage Requirement Official Condition
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Protection Protect from excess heat, moisture, and direct light; do not store in the bathroom.
Container Rule Keep in the original container and ensure it is tightly closed.
Child Safety Must be kept out of the sight and reach of children.

To maintain stability, the medication must not be frozen. Regarding disposal, unused or expired Flupamid tablets should be discarded through an official medicine take-back program. It is prohibited to flush the tablets down the toilet or dispose of them via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flupamid found in:

A-Z Index: